The EMA has granted approval for ProStrakan Group to market SANCUSO (Granisetron Transdermal System) in the EU, with 3M Drug Delivery Systems as the manufacturer. SANCUSO, introduced in the U.S. in 2008, is the only treatment for chemotherapy-induced nausea and vomiting that does not require pills or intravenous administration. The transdermal patch is applied to the upper arm and can be worn for seven days, providing continuous transdermal delivery to control nausea and vomiting.   “SANCUSO is ...